(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are PORCELEYNE FLES, EXPLOSIFS PROD.CHI, and PETROLIA.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| PORCELEYNE FLES (PORF.AS) | 11.50 | 9.52% | 2023-06-22 11:04:19 |
| EXPLOSIFS PROD.CHI (EXPL.PA) | 118.00 | 8.26% | 2023-06-22 11:49:07 |
| PETROLIA (PSE.OL) | 4.10 | 7.61% | 2023-06-22 11:32:57 |
| VISTIN PHARMA (VISTN.OL) | 22.40 | 6.16% | 2023-06-22 11:35:16 |
| ELECTROMAGNET GEO (EMGS.OL) | 3.20 | 5.96% | 2023-06-22 11:22:09 |
| WAGA ENERGY (WAGA.PA) | 27.85 | 5.69% | 2023-06-22 11:05:42 |
| SES (SESG.PA) | 5.11 | 5.33% | 2023-06-22 08:03:16 |
| CM.COM (CMCOM.AS) | 9.48 | 4.64% | 2023-06-22 08:01:44 |
| TEKNA HOLDING (TEKNA.OL) | 7.00 | 4.48% | 2023-06-22 11:34:56 |
| SOGN SPAREBANK (SOGN.OL) | 148.00 | 3.5% | 2023-06-22 11:34:12 |
The three biggest losers today are BERGENBIO, BEAULIEU-AV. CERT, and NORDIC NANOVECTOR.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| BERGENBIO (BGBIO.OL) | 0.10 | -62.59% | 2023-06-22 11:21:13 |
| BEAULIEU-AV. CERT (BEAB.BR) | 4.48 | -13.85% | 2023-06-22 11:06:30 |
| NORDIC NANOVECTOR (NANOV.OL) | 1.93 | -11.87% | 2023-06-22 11:31:58 |
| ATLANTIC SAPPHIRE (ASA.OL) | 7.11 | -10.9% | 2023-06-22 11:20:46 |
| GYLDENDAL (GYL.OL) | 500.00 | -9.91% | 2023-06-22 08:30:30 |
| GENFIT (GNFT.PA) | 3.77 | -9.81% | 2023-06-22 11:50:39 |
| PCI BIOTECH HOLD (PCIB.OL) | 2.20 | -9.47% | 2023-06-22 11:32:48 |
| MIKO (MIKO.BR) | 67.50 | -8.78% | 2023-06-22 11:15:45 |
| CRAYON GROUP HOLD (CRAYN.OL) | 107.60 | -8.66% | 2023-06-22 11:21:54 |
| MOLTEN VENTURES (GRW.IR) | 2.92 | -8.18% | 2023-06-22 08:18:15 |
Winners today
1. PORCELEYNE FLES (PORF.AS)
9.52% Price Change
B.V. Delftsch Aardewerkfabriek ''De Porceleyne Fles Anno 1653'' produces and sells Delft Blue decorative pottery and modern pottery in the Netherlands. The company offers its products portfolio under the Royal Leerdam Crystal brand. B.V. Delftsch Aardewerkfabriek 'De Porceleyne Fles Anno 1653' was founded in 1653 and is based in Delft, the Netherlands.
AEX-Index ended the session with PORCELEYNE FLES jumping 9.52% to €11.50 on Thursday while AEX-Index dropped 0% to €759.17.
Earnings Per Share
As for profitability, PORCELEYNE FLES has a trailing twelve months EPS of €0.49.
PE Ratio
PORCELEYNE FLES has a trailing twelve months price to earnings ratio of 23.47. Meaning, the purchaser of the share is investing €23.47 for every euro of annual earnings.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PORCELEYNE FLES’s stock is considered to be overbought (>=80).
More news about PORCELEYNE FLES.
2. EXPLOSIFS PROD.CHI (EXPL.PA)
8.26% Price Change
EPC Groupe engages in the manufacture, storage, and distribution of explosives in Europe, Africa, Asia Pacific, and the Americas. The company also provides drilling and mining services; logistics services; and demolition services, including mechanical demolition, deconstruction and blasting of buildings, waste management, and asbestos removal. In addition, it produces 2-ethylhexyl nitrate, a diesel fuel additive that reduces emissions and enhances diesel engine performance. It serves customers operating in the mining, cement, aggregates, civil engineering, and defense industries. EPC Groupe was founded in 1893 and is headquartered in Paris, France. EPC Groupe is a subsidiary of Ste E.J. Barbier.
CAC 40 ended the session with EXPLOSIFS PROD.CHI rising 8.26% to €118.00 on Thursday while CAC 40 slid 0.79% to €7,203.28.
Earnings Per Share
As for profitability, EXPLOSIFS PROD.CHI has a trailing twelve months EPS of €4.94.
PE Ratio
EXPLOSIFS PROD.CHI has a trailing twelve months price to earnings ratio of 23.89. Meaning, the purchaser of the share is investing €23.89 for every euro of annual earnings.
Volume
Today’s last reported volume for EXPLOSIFS PROD.CHI is 739 which is 284.89% above its average volume of 192.
More news about EXPLOSIFS PROD.CHI.
3. PETROLIA (PSE.OL)
7.61% Price Change
Petrolia SE, together with its subsidiaries, sells and rents energy service equipment to energy industry in Norway, rest of Europe, Asia, and Australia. It operates through two segments, Energy and Energy Service. The company engages in the exploration and production of oil and gas, as well as produces hydrogen and ammonia. It also offers drill pipes, test strings and tubing, and other equipment, as well as casing, handling, and auxiliary tools; and equipment inspection and maintenance services. In addition, the company offers casing and tubing running, drilling, and make and brake services. It serves energy companies, drilling contractors, and energy service companies. The company was formerly known as Petrolia E&P Holdings SE and changed its name to Petrolia SE in January 2013. Petrolia SE was founded in 1997 and is based in Limassol, Cyprus.
Oslo Børs Benchmark Index_GI ended the session with PETROLIA rising 7.61% to €4.10 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI slid 1.59% to €1,208.10, following the last session’s downward trend on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, PETROLIA has a trailing twelve months EPS of kr-0.32.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.9%.
Moving Average
PETROLIA’s worth is higher than its 50-day moving average of kr3.87 and below its 200-day moving average of kr4.38.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 55.5M for the twelve trailing months.
Volatility
PETROLIA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.20%, a positive 0.22%, and a positive 3.16%.
PETROLIA’s highest amplitude of average volatility was 2.74% (last week), 4.02% (last month), and 3.16% (last quarter).
More news about PETROLIA.
4. VISTIN PHARMA (VISTN.OL)
6.16% Price Change
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with VISTIN PHARMA jumping 6.16% to €22.40 on Thursday while Oslo Børs Benchmark Index_GI slid 1.59% to €1,208.10.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr0.15.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 149.33. Meaning, the purchaser of the share is investing kr149.33 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.81%.
Volume
Today’s last reported volume for VISTIN PHARMA is 15953 which is 50.12% below its average volume of 31986.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VISTIN PHARMA’s EBITDA is 3.08.
Moving Average
VISTIN PHARMA’s worth is above its 50-day moving average of kr21.39 and way higher than its 200-day moving average of kr16.95.
Yearly Top and Bottom Value
VISTIN PHARMA’s stock is valued at kr22.40 at 22:40 EST, way under its 52-week high of kr25.10 and way higher than its 52-week low of kr11.25.
More news about VISTIN PHARMA.
5. ELECTROMAGNET GEO (EMGS.OL)
5.96% Price Change
Electromagnetic Geoservices ASA, together with its subsidiaries, provides electromagnetic (EM) surveying services to the offshore oil and gas exploration industry. It is involved in the planning, acquisition, processing, modelling, interpretation, and integration of EM data. The company uses its patented EM survey method to find hydrocarbons in offshore reservoirs. It engages in the provision of controlled-source EM surveying and magneto telluric surveying; imaging and interpretation; rental of software and cluster; and training services. The company has operations in Europe, the Middle East, Africa, Norway, North and South America, Asia, and the Pacific Ocean. Electromagnetic Geoservices ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ELECTROMAGNET GEO rising 5.96% to €3.20 on Thursday, after two sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 1.59% to €1,208.10, following the last session’s downward trend on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, ELECTROMAGNET GEO has a trailing twelve months EPS of kr0.86.
PE Ratio
ELECTROMAGNET GEO has a trailing twelve months price to earnings ratio of 3.72. Meaning, the purchaser of the share is investing kr3.72 for every norwegian krone of annual earnings.
Volatility
ELECTROMAGNET GEO’s last week, last month’s, and last quarter’s current intraday variation average was a positive 4.14%, a negative 0.39%, and a positive 3.92%.
ELECTROMAGNET GEO’s highest amplitude of average volatility was 5.69% (last week), 5.36% (last month), and 3.92% (last quarter).
More news about ELECTROMAGNET GEO.
6. WAGA ENERGY (WAGA.PA)
5.69% Price Change
Waga Energy Société anonyme, together with its subsidiaries, develops biomethane injections projects serving the energy transitions. It is involved in the design, development, financing, construction, installation, and exploitation solutions, as well as sale of biomethane. The company was incorporated in 2015 and is headquartered in Meylan, France.
CAC 40 ended the session with WAGA ENERGY rising 5.69% to €27.85 on Thursday, following the last session’s upward trend. CAC 40 fell 0.79% to €7,203.28, after three sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, WAGA ENERGY has a trailing twelve months EPS of €-0.5.
Volume
Today’s last reported volume for WAGA ENERGY is 4622 which is 12.54% below its average volume of 5285.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, WAGA ENERGY’s stock is considered to be oversold (<=20).
More news about WAGA ENERGY.
7. SES (SESG.PA)
5.33% Price Change
SES S.A. provides satellite-based data transmission capacity and ancillary services worldwide. It offers content connectivity solutions, including network spanning satellite and ground infrastructure to create, deliver, and manage video and data solutions. The company also provides data connectivity services through its fleet of geostationary earth orbit and medium earth orbit satellites to government, aeronautical, maritime, telecommunications companies, mobile network operators, and cloud industries. The company also offers video services, which includes end-to-end managed services to audience; and provides multi-screen and multi-device viewing experiences on linear channels, video-on-demand, streaming platforms, and social media sites for broadcasters, platform operators, and sports organizations. In addition, it provides linear video aggregation and distribution, such as direct-to-home, direct-to-cable, and internet protocol TV households; hybrid video platform solutions; channel management solutions comprising playout; and live feeds and multiple redundancy content. The company was founded in 1985 and is headquartered in Betzdorf, Luxembourg.
CAC 40 ended the session with SES jumping 5.33% to €5.11 on Thursday while CAC 40 fell 0.79% to €7,203.28.
Earnings Per Share
As for profitability, SES has a trailing twelve months EPS of €-0.23.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 133.3% and a drop 65% for the next.
More news about SES.
8. CM.COM (CMCOM.AS)
4.64% Price Change
CM.com N.V. provides cloud software for conversational commerce worldwide. It operates in four segments: Communication Platform as a Service (CPaaS), Software as a Service (SaaS), Payment Services, and Ticketing. Its products include Mobile Service Cloud, an all-in-one customer service software; Conversational AI Cloud for automating customer service with AI powered chats and voice bots; Mobile Marketing Cloud, an omnichannel customer engagement solution for businesses; Ticketing that offers event, seated, and attraction ticketing services; Sign, which allows the user to complete contracts, agreements, and documents without printing and scanning; communications platform for mobile messaging and voice for business communication; and payments platform that accepts online and POS payments. CM.com N.V. was founded in 1999 and is headquartered in Breda, the Netherlands.
AEX-Index ended the session with CM.COM jumping 4.64% to €9.48 on Thursday while AEX-Index slid 0% to €759.17.
Earnings Per Share
As for profitability, CM.COM has a trailing twelve months EPS of €-1.49.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.1%.
Volatility
CM.COM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.20%, a positive 0.46%, and a positive 2.31%.
CM.COM’s highest amplitude of average volatility was 3.05% (last week), 2.86% (last month), and 2.31% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 283.23M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CM.COM’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for CM.COM is 48346 which is 28.71% below its average volume of 67816.
More news about CM.COM.
9. TEKNA HOLDING (TEKNA.OL)
4.48% Price Change
Tekna Holding ASA develops, manufactures, and sells micro and nano powders, and plasma process solutions in North America, Europe, Asia, and internationally. The company offers spherical powders, such as titanium, nickel, and aluminum alloys, as well as tungsten and tantalum; and nanopowders, including nickel nanopowder, silicon nanopowder, copper nanopowder, and boron nitride nanotubes for use in additive manufacturing, metal injection molding, thermal spray, and hot isostatic pressing. It serves aviation, aerospace, medical, mining and drilling, energy storage, and microelectronics industries. The company was founded in 1990 and is headquartered in Sherbrooke, Canada. Tekna Holding ASA is a subsidiary of Arendals Fossekompani ASA.
Oslo Børs Benchmark Index_GI ended the session with TEKNA HOLDING jumping 4.48% to €7.00 on Thursday while Oslo Børs Benchmark Index_GI fell 1.59% to €1,208.10.
Earnings Per Share
As for profitability, TEKNA HOLDING has a trailing twelve months EPS of kr-1.07.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.23%.
Yearly Top and Bottom Value
TEKNA HOLDING’s stock is valued at kr7.00 at 22:40 EST, way under its 52-week high of kr20.00 and way above its 52-week low of kr5.30.
More news about TEKNA HOLDING.
10. SOGN SPAREBANK (SOGN.OL)
3.5% Price Change
Sogn Sparebank provides various banking products and services in Norway. The company offers savings products; home loans and small loans, as well as loans for cars and other vehicles; credit and other cards; and mobile and online banking services. It also provides bank guarantees, construction loans, overdraft, and business loans, as well as leasing and securities trading services. In addition, the company offers home and leisure, animals, damage, car, liability, work machine, data attack, farm building, operating equipment and crop, property damage, health, homeowners, agriculture, craftsman, commercial vehicle, business, and personnel insurance products. Sogn Sparebank was founded in 1846 and is based in Årdalstangen, Norway.
Oslo Børs Benchmark Index_GI ended the session with SOGN SPAREBANK jumping 3.5% to €148.00 on Thursday while Oslo Børs Benchmark Index_GI fell 1.59% to €1,208.10.
Earnings Per Share
As for profitability, SOGN SPAREBANK has a trailing twelve months EPS of kr29.36.
PE Ratio
SOGN SPAREBANK has a trailing twelve months price to earnings ratio of 5.04. Meaning, the purchaser of the share is investing kr5.04 for every norwegian krone of annual earnings.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 20.7% and 34.4%, respectively.
More news about SOGN SPAREBANK.
Losers Today
1. BERGENBIO (BGBIO.OL)
-62.59% Price Change
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.
Oslo Børs Benchmark Index_GI ended the session with BERGENBIO sliding 62.59% to €0.10 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI slid 1.59% to €1,208.10, following the last session’s downward trend on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, BERGENBIO has a trailing twelve months EPS of kr-3.15.
Volume
Today’s last reported volume for BERGENBIO is 57590900 which is 2261.04% above its average volume of 2439220.
Volatility
BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.46%, a negative 2.20%, and a positive 8.58%.
BERGENBIO’s highest amplitude of average volatility was 9.82% (last week), 14.90% (last month), and 8.58% (last quarter).
More news about BERGENBIO.
2. BEAULIEU-AV. CERT (BEAB.BR)
-13.85% Price Change
Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.
BEL 20 ended the session with BEAULIEU-AV. CERT dropping 13.85% to €4.48 on Thursday while BEL 20 dropped 0.32% to €3,547.85.
Volume
Today’s last reported volume for BEAULIEU-AV. CERT is 90 which is 3.22% below its average volume of 93.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BEAULIEU-AV. CERT’s stock is considered to be oversold (<=20).
More news about BEAULIEU-AV. CERT.
3. NORDIC NANOVECTOR (NANOV.OL)
-11.87% Price Change
Nordic Nanovector ASA, a biopharmaceutical company, develops therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting radioimmunotherapy for the treatment of patients with non-hodgkin lymphoma. Its preclinical development products include Humalutin for treatment of non-Hodgkin's lymphoma; Alpha37, a CD37-targeting radioimmunotherapy for treating chronic lymphatic leukemia; and Multiple fully humanized anti-CD37 antibodies for treatment of haematological cancers and autoimmune diseases. The company is also developing 89Zr-NNV003, a CD37-targeting companion PET diagnostic for detection and dosimetry of CD37 expressing tumors. The company has collaboration agreements with Orano Med; Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania development of a CD37-targeting CAR-T in haematological cancers. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NORDIC NANOVECTOR sliding 11.87% to €1.93 on Thursday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 1.59% to €1,208.10, following the last session’s downward trend on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, NORDIC NANOVECTOR has a trailing twelve months EPS of kr-2.61.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -304.6%.
Volatility
NORDIC NANOVECTOR’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.10%, a positive 9.95%, and a positive 9.36%.
NORDIC NANOVECTOR’s highest amplitude of average volatility was 6.52% (last week), 20.12% (last month), and 9.36% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORDIC NANOVECTOR’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for NORDIC NANOVECTOR is 5420720 which is 75.56% above its average volume of 3087650.
More news about NORDIC NANOVECTOR.
4. ATLANTIC SAPPHIRE (ASA.OL)
-10.9% Price Change
Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.
Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE dropping 10.9% to €7.11 on Thursday, after three successive sessions in a row of losses. Oslo Børs Benchmark Index_GI fell 1.59% to €1,208.10, following the last session’s downward trend on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-4.74.
More news about ATLANTIC SAPPHIRE.
5. GYLDENDAL (GYL.OL)
-9.91% Price Change
Gyldendal ASA, through its subsidiaries publishes and sells books in Norway. It also operates 143 bookstores and an online bookstore. In addition, it publishes dictionaries and encyclopedias; and provides logistics and reporting services to the book industry. The company was founded in 1925 and is based in Oslo, Norway. Gyldendal ASA is a subsidiary of Erik Must AS.
Oslo Børs Benchmark Index_GI ended the session with GYLDENDAL dropping 9.91% to €500.00 on Thursday, after five sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 1.59% to €1,208.10, following the last session’s downward trend on what was an all-around bearish trend exchanging session today.
Earnings Per Share
As for profitability, GYLDENDAL has a trailing twelve months EPS of kr8.82.
PE Ratio
GYLDENDAL has a trailing twelve months price to earnings ratio of 56.69. Meaning, the purchaser of the share is investing kr56.69 for every norwegian krone of annual earnings.
Volume
Today’s last reported volume for GYLDENDAL is 2 which is 66.66% below its average volume of 6.
More news about GYLDENDAL.
6. GENFIT (GNFT.PA)
-9.81% Price Change
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company develops Elafibranor, which is in Phase III clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; VS-01 for the treatment of Urea Cycle Disorder (UCD) and Organic Acidemia Disorder (OAD); GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and VS-01-ACLF and Nitazoxanide (NTZ), which is in Phase 1 trial to treat acute-on-chronic liver failure, as well as VS-02-HE, which is in preclinical trial for the treatment of Reduction of Hyperammonemia and the Stabilization of Blood Ammonia. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. The company was incorporated in 1999 and is headquartered in Loos, France.
CAC 40 ended the session with GENFIT falling 9.81% to €3.77 on Thursday, following the last session’s upward trend. CAC 40 fell 0.79% to €7,203.28, after three successive sessions in a row of losses, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, GENFIT has a trailing twelve months EPS of €-0.48.
Volume
Today’s last reported volume for GENFIT is 410753 which is 307.93% above its average volume of 100692.
Volatility
GENFIT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.09%, a positive 0.37%, and a positive 1.84%.
GENFIT’s highest amplitude of average volatility was 0.75% (last week), 1.91% (last month), and 1.84% (last quarter).
More news about GENFIT.
7. PCI BIOTECH HOLD (PCIB.OL)
-9.47% Price Change
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD falling 9.47% to €2.20 on Thursday while Oslo Børs Benchmark Index_GI slid 1.59% to €1,208.10.
Earnings Per Share
As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.93.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.97%.
Yearly Top and Bottom Value
PCI BIOTECH HOLD’s stock is valued at kr2.20 at 22:40 EST, way below its 52-week high of kr5.96 and way above its 52-week low of kr1.52.
Volatility
PCI BIOTECH HOLD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.31%, a positive 2.42%, and a positive 4.94%.
PCI BIOTECH HOLD’s highest amplitude of average volatility was 9.58% (last week), 7.42% (last month), and 4.94% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PCI BIOTECH HOLD’s stock is considered to be oversold (<=20).
Moving Average
PCI BIOTECH HOLD’s worth is way higher than its 50-day moving average of kr1.97 and above its 200-day moving average of kr2.09.
More news about PCI BIOTECH HOLD.
8. MIKO (MIKO.BR)
-8.78% Price Change
Miko NV, together with its subsidiaries, owns and manages coffee services in Belgium, France, the Netherlands, the United Kingdom, Germany, Denmark, Norway, Sweden, Poland, the Czech Republic, Slovakia, and Australia. It also places coffee and vending machines for companies, public institutions, and universities. The company offers a range of soft drinks, snacks, and healthy snacks, as well as milk, tea, and hot chocolates; and technical services. Miko NV was founded in 1801 and is based in Turnhout, Belgium.
BEL 20 ended the session with MIKO sliding 8.78% to €67.50 on Thursday while BEL 20 fell 0.32% to €3,547.85.
Earnings Per Share
As for profitability, MIKO has a trailing twelve months EPS of €-30.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.21%.
Volume
Today’s last reported volume for MIKO is 2097 which is 348.07% above its average volume of 468.
Yearly Top and Bottom Value
MIKO’s stock is valued at €67.50 at 22:40 EST, below its 52-week low of €74.00.
More news about MIKO.
9. CRAYON GROUP HOLD (CRAYN.OL)
-8.66% Price Change
Crayon Group Holding ASA, together with its subsidiaries, operates as an IT advisory company. It operates through Software & Cloud Direct, Software & Cloud Channel, Software & Cloud Economics, and Consulting segments. The company provides assess and migrate services, including cloud migration assessment, maturity assessment, cloud infrastructure advisory and migration, cloud POC, cloud tenant migration, cloud connectivity, modern workplace migration, and cloud identity; govern and optimize services comprising IT governance, license optimization, software and cloud economics, and SAM tool; operate and support services, such as modern workplace adoption, software and cloud advisory service desk, cloud managed services, and support program services; and data platform and AI solutions services. It also offers software and IT asset management services. The company has operations in the Nordics, Europe, the Asia-Pacific, the Middle East and Africa, and the United States. Crayon Group Holding ASA was incorporated in 2011 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with CRAYON GROUP HOLD falling 8.66% to €107.60 on Thursday while Oslo Børs Benchmark Index_GI dropped 1.59% to €1,208.10.
Earnings Per Share
As for profitability, CRAYON GROUP HOLD has a trailing twelve months EPS of kr-1.36.
Volume
Today’s last reported volume for CRAYON GROUP HOLD is 281256 which is 28.06% below its average volume of 390966.
More news about CRAYON GROUP HOLD.
10. MOLTEN VENTURES (GRW.IR)
-8.18% Price Change
Molten Ventures Plc, formerly known as Draper Esprit plc, is a private equity and venture capital firm specializing in any stage in the lifecycle of a business from seed and series A stage, growth capital to pre-IPO investments, late stage, start-ups, cross-stage investments, buyouts, PIPES, and also makes direct and secondary investments in portfolio companies. It also seeks to buy entire funds from other tech investors. The firm primarily invests in companies from pre-revenue stage upwards. It primarily invests in technology oriented business. The firm typically invests in digital technology, consumer, commerce, enterprise and data, systems and semiconductors, financial technology, internet, mobile, media, telecom, consumer technology, enterprise technology, SaaS, fintech, deeptech, digital health & wellness and healthcare sectors, prop tech, software, hardware, medical technology, and life sciences sectors. It invests in companies based in Europe, United states, Austria, Belgium, Denmark, Germany, Finland, France, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Ireland, and United Kingdom. The firm seeks to invest between $0.02 million and €10 million ($10.88 million) in rounds up to €1 million ($1.09 million) and €30 million ($32.63 million). It invests 30 percent of its corpus in very early stage companies with less than $5 million in revenues. The firm seeks to make minority and majority investments. Molten Ventures Plc was founded in 1984 and is based in London, United Kingdom with an additional offices in Dublin, Ireland.
ISEQ All Share ended the session with MOLTEN VENTURES falling 8.18% to €2.92 on Thursday, after two successive sessions in a row of losses. ISEQ All Share fell 0.86% to €8,580.63, after three consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, MOLTEN VENTURES has a trailing twelve months EPS of €-1.71.
More news about MOLTEN VENTURES.
Stay up to date with our winners and losers daily report
